Complex Injectable Market

Complex Injectable Market by Category (Vials, Cartridges, Bottles, and Ampules) Applications (Cancer, Diabetes, CNS, Infections, Cardiovascular Diseases, and Others) End-users (Hospital & Clinics, Online Pharmacies, Home Care Settings, and Others), and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2027

  • Report ID: HC-547
  • Author: Growth Market Reports
  • Rating: 4.8
  • Total Reviews: 2
  • No. Of Pages: 190
  • Format:
  • Pub. Date: Upcoming
  • Share:

The global complex injection market size was valued at USD 483.45 billion in 2019 and is estimated to reach USD 1251.28 billion by 2028, expanding at a CAGR of 12.9% during the forecast period, 2021 – 2028. Growth of the market is attributed to change in the forms of medication.
 

Complex Injectable Market Key Takeaways


Injectable systems help in delivering drugs to the target site, allowing it to be specific and localized. Patients relying on medication prefer advance procedures over conventional injection devices. Taking this into consideration, the rising demand for effective and convenient systems for drug delivery is expected to create remunerative opportunity for the manufactures to develop effective, sophisticated, and customer-friendly devices.

According to World Health Organization (WHO), the Covid-19 pandemic has affected the demand and supply of certain injectable drug delivery systems. It has generated immense opportunities for the injectable market. Government’s support in developing such technologies is expected to boost the global injectables market.

Market Trends, Drivers, Restraints, and Opportunities

  • Factors such as increasing chronic diseases, rising preference for self-injection devices, advancements in technology, increasing demand for biologics market, preference of advanced modes of drug delivery, and increasing number of needle infections are projected to drive the market.
  • Changing preference of patients from traditional syringes to pre-filled syringes is expected to drive the market.
  • The Covid-19 outbreak increased the demand for technologically advanced drug delivering system, which is projected to boost the market.
  • High cost associated with manufacturing advanced injectable devices is anticipated to hamper the market growth.
  • Factors such as complex nature and high manufacturing costs are anticipated to hinder the market growth.
  • Injectables are infectious in nature and highly toxic; therefore a great level of monitoring is required during their manufacturing, distribution, and storing.
  • Global complex injectable market plays an important role in the improvement and growth of medical industry and has immense growth opportunities.

Scope of the Report

The report on the global complex injectable market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

 
Attributes Details
Report Title Global Complex Injectable Market-Global Industry Analysis, Growth, Share, Size, Trends, and Forecast
Base Year 2020
Historic Data 2018–2019
Forecast Period 2021–2027
Segmentation Category (Vials, Cartridges, Bottles, and Ampules), Applications (Cancer, Diabetes, CNS, Infections, Cardiovascular Diseases, and Others), End-users (Hospital & Clinics, Online Pharmacies, Home Care Settings, and Others)
Regional Scope Asia Pacific, North America, Latin America, Europe, and Middle East & Africa
Report Coverage Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast
Key Players Covered in the Report Eli Lilly, Pfizer, Teva Pharmaceutical Industries, Hospira, Hikma Pharmaceutical, Johnson & Johnson Pharmaceutical, Novo Nordisk, and Abbvie

 

Global Complex Injectable Market Segment insights

Vials segment to account for a major market share
Based on category, the global complex injectable market is fragmented into vials, cartridges, bottles, and ampules. The vials segment accounted for a large market share in 2020 and is expected to expand at a substantial CAGR during the forecast period. Vials are commonly familiar tool used in the modern injectable market. It typically seals with a stopper of rubber screw-cap or glass-stopper and contains medicine that are stored and used on regular basis. Patients are opting for these medical tools, due to its affordable price, availability, common medical practices, and reliability. The Ampules segment is anticipated to exhibit a high CAGR, owing to the investment on innovation of advanced medicine industry. Ampules consist of a sealed glass container containing injectable medicine and is one-time use only, which acts as a restraint and restricts the market growth.

The Cancer segment is estimated to expand at a rapid pace
On the basis of applications, the global complex injectable market is segregated into cancer, diabetes, CNS, infections, cardiovascular diseases, and others. The cancer segment is expected to expand at a substantial CAGR during the forecast period, owing to the need for continuous treatment. Cytarabine lipid complex is commonly used for cancer treatment. It is known as antimetabolites, which helps in slowing or stopping the growth of cancer cells. Therefore, advancement in injectables is projected to drive the market during the forecast period.

The hospitals and clinics segment is projected to constitute a significant market share
Based on end-users, the market is segmented into hospital & clinics, online pharmacies, home care settings, and others. The hospital and clinics segment accounts for a key share of the market. The online pharmacies segment is anticipated to expand at a rapid pace during the forecast period. Hospitals and clinics are the chief customers of the global complex injectable market. After the covid-19 outbreak the demand increased at an enormous rate, which in turn, is projected to boost the market.
 

Complex Injectable Market By End Users


The market in North America is projected to expand at a robust CAGR during the forecast period
In terms of regions, the market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America holds the maximum share of the global complex injectable market in terms of revenue, demand, and consumption. Growth of the market is attributed to rising investment in the advance healthcare along with increasing chronic diseases. The market in Asia Pacific is anticipated to expand at a rapid rate during the forecast period. Growing investment in the healthcare sector is estimated to boost the market during the forecast period.

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Complex Injectable Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Complex Injectable Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Complex Injectable Market - Supply Chain
  4.5. Global Complex Injectable Market Forecast
     4.5.1. Complex Injectable Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Complex Injectable Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Complex Injectable Market Absolute $ Opportunity
5. Global Complex Injectable Market Analysis and Forecast by Applications
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Applications
     5.2.2. Y-o-Y Growth Projections by Applications
  5.3. Complex Injectable Market Size and Volume Forecast by Applications
     5.3.1. Cancer
     5.3.2.  Diabetes
     5.3.3.  CNS
     5.3.4.  Infections
     5.3.5.  Cardiovascular Diseases
  5.4. Absolute $ Opportunity Assessment by Applications
  5.5. Market Attractiveness/Growth Potential Analysis by Applications
6. Global Complex Injectable Market Analysis and Forecast by End Users
  6.1. Market Trends
  6.2. Introduction
     6.2.1. Basis Point Share (BPS) Analysis by End Users
     6.2.2. Y-o-Y Growth Projections by End Users
  6.3. Complex Injectable Market Size and Volume Forecast by End Users
     6.3.1. Hospital & Clinics
     6.3.2. Online Pharmacies
     6.3.3.  Home Care Settings
  6.4. Absolute $ Opportunity Assessment by End Users
  6.5. Market Attractiveness/Growth Potential Analysis by End Users
7. Global Complex Injectable Market Analysis and Forecast by Region
  7.1. Market Trends
  7.2. Introduction
     7.2.1. Basis Point Share (BPS) Analysis by Region
     7.2.2. Y-o-Y Growth Projections by Region
  7.3. Complex Injectable Market Size and Volume Forecast by Region
     7.3.1. North America
     7.3.2. Latin America
     7.3.3. Europe
     7.3.4. Asia Pacific
     7.3.5. Middle East and Africa (MEA)
  7.4. Absolute $ Opportunity Assessment by Region
  7.5. Market Attractiveness/Growth Potential Analysis by Region
  7.6. Global Complex Injectable Demand Share Forecast, 2019-2026
8. North America Complex Injectable Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
  8.2. North America Complex Injectable Market Size and Volume Forecast by Country
     8.2.1. U.S.
     8.2.2. Canada
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. North America Complex Injectable Market Size and Volume Forecast by Applications
     8.4.1. Cancer
     8.4.2.  Diabetes
     8.4.3.  CNS
     8.4.4.  Infections
     8.4.5.  Cardiovascular Diseases
  8.5. Basis Point Share (BPS) Analysis by Applications
  8.6. Y-o-Y Growth Projections by Applications
  8.7. North America Complex Injectable Market Size and Volume Forecast by End Users
     8.7.1. Hospital & Clinics
     8.7.2. Online Pharmacies
     8.7.3.  Home Care Settings
  8.8. Basis Point Share (BPS) Analysis by End Users
  8.9. Y-o-Y Growth Projections by End Users
  8.10. Market Attractiveness/Growth Potential Analysis
     8.10.1. By Country
     8.10.2. By Product Type
     8.10.3. By Application
  8.11. North America Complex Injectable Demand Share Forecast, 2019-2026
9. Latin America Complex Injectable Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Latin America Average Pricing Analysis
  9.2. Latin America Complex Injectable Market Size and Volume Forecast by Country
      9.2.1. Brazil
      9.2.2. Mexico
      9.2.3. Rest of Latin America
   9.3. Absolute $ Opportunity Assessment by Country
  9.4. Latin America Complex Injectable Market Size and Volume Forecast by Applications
     9.4.1. Cancer
     9.4.2.  Diabetes
     9.4.3.  CNS
     9.4.4.  Infections
     9.4.5.  Cardiovascular Diseases
  9.5. Basis Point Share (BPS) Analysis by Applications
  9.6. Y-o-Y Growth Projections by Applications
  9.7. Latin America Complex Injectable Market Size and Volume Forecast by End Users
     9.7.1. Hospital & Clinics
     9.7.2. Online Pharmacies
     9.7.3.  Home Care Settings
  9.8. Basis Point Share (BPS) Analysis by End Users
  9.9. Y-o-Y Growth Projections by End Users
  9.10. Market Attractiveness/Growth Potential Analysis
     9.10.1. By Country
     9.10.2. By Product Type
     9.10.3. By Application
  9.11. Latin America Complex Injectable Demand Share Forecast, 2019-2026
10. Europe Complex Injectable Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Europe Average Pricing Analysis
  10.2. Europe Complex Injectable Market Size and Volume Forecast by Country
     10.2.1. Germany
     10.2.2. France
     10.2.3. Italy
     10.2.4. U.K.
     10.2.5. Spain
     10.2.6. Russia
     10.2.7. Rest of Europe
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Europe Complex Injectable Market Size and Volume Forecast by Applications
     10.4.1. Cancer
     10.4.2.  Diabetes
     10.4.3.  CNS
     10.4.4.  Infections
     10.4.5.  Cardiovascular Diseases
  10.5. Basis Point Share (BPS) Analysis by Applications
  10.6. Y-o-Y Growth Projections by Applications
  10.7. Europe Complex Injectable Market Size and Volume Forecast by End Users
     10.7.1. Hospital & Clinics
     10.7.2. Online Pharmacies
     10.7.3.  Home Care Settings
  10.8. Basis Point Share (BPS) Analysis by End Users
  10.9. Y-o-Y Growth Projections by End Users
  10.10. Market Attractiveness/Growth Potential Analysis
     10.10.1. By Country
     10.10.2. By Product Type
     10.10.3. By Application
  10.11. Europe Complex Injectable Demand Share Forecast, 2019-2026
11. Asia Pacific Complex Injectable Market Analysis and Forecast
  11.1. Introduction
     11.1.1. Basis Point Share (BPS) Analysis by Country
     11.1.2. Y-o-Y Growth Projections by Country
     11.1.3. Asia Pacific Average Pricing Analysis
  11.2. Asia Pacific Complex Injectable Market Size and Volume Forecast by Country
     11.2.1. China
     11.2.2. Japan
     11.2.3. South Korea
     11.2.4. India
     11.2.5. Australia
     11.2.6. Rest of Asia Pacific (APAC)
  11.3. Absolute $ Opportunity Assessment by Country
  11.4. Asia Pacific Complex Injectable Market Size and Volume Forecast by Applications
     11.4.1. Cancer
     11.4.2.  Diabetes
     11.4.3.  CNS
     11.4.4.  Infections
     11.4.5.  Cardiovascular Diseases
  11.5. Basis Point Share (BPS) Analysis by Applications
  11.6. Y-o-Y Growth Projections by Applications
  11.7. Asia Pacific Complex Injectable Market Size and Volume Forecast by End Users
     11.7.1. Hospital & Clinics
     11.7.2. Online Pharmacies
     11.7.3.  Home Care Settings
  11.8. Basis Point Share (BPS) Analysis by End Users
  11.9. Y-o-Y Growth Projections by End Users
  11.10. Market Attractiveness/Growth Potential Analysis
     11.10.1. By Country
     11.10.2. By Product Type
     11.10.3. By Application
  11.11. Asia Pacific Complex Injectable Demand Share Forecast, 2019-2026
12. Middle East & Africa Complex Injectable Market Analysis and Forecast
  12.1. Introduction
     12.1.1. Basis Point Share (BPS) Analysis by Country
     12.1.2. Y-o-Y Growth Projections by Country
     12.1.3. Middle East & Africa Average Pricing Analysis
  12.2. Middle East & Africa Complex Injectable Market Size and Volume Forecast by Country
     12.2.1. Saudi Arabia
     12.2.2. South Africa
     12.2.3. UAE
     12.2.4. Rest of Middle East & Africa (MEA)
  12.3. Absolute $ Opportunity Assessment by Country
  12.4. Middle East & Africa Complex Injectable Market Size and Volume Forecast by Applications
     12.4.1. Cancer
     12.4.2.  Diabetes
     12.4.3.  CNS
     12.4.4.  Infections
     12.4.5.  Cardiovascular Diseases
  12.5. Basis Point Share (BPS) Analysis by Applications
  12.6. Y-o-Y Growth Projections by Applications
  12.7. Middle East & Africa Complex Injectable Market Size and Volume Forecast by End Users
     12.7.1. Hospital & Clinics
     12.7.2. Online Pharmacies
     12.7.3.  Home Care Settings
  12.8. Basis Point Share (BPS) Analysis by End Users
  12.9. Y-o-Y Growth Projections by End Users
  12.10. Market Attractiveness/Growth Potential Analysis
     12.10.1. By Country
     12.10.2. By Product Type
     12.10.3. By Application
  12.11. Middle East & Africa Complex Injectable Demand Share Forecast, 2019-2026
13. Competition Landscape
  13.1. Global Complex Injectable Market: Market Share Analysis
  13.2. Complex Injectable Distributors and Customers
  13.3. Complex Injectable Market: Competitive Dashboard
  13.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     13.4.1. Eli Lilly
     13.4.2. Pfizer
     13.4.3. Teva Pharmaceutical Industries
     13.4.4. Hospira
     13.4.5. Hikma Pharmaceutical
     13.4.6. Johnson & Johnson Pharmaceutical
     13.4.7. Novo Nordisk
     13.4.8. Abbvie

Segments Covered in the Report
The global complex injectable market has been segmented on the basis of:-

Category

  • Vials
  • Cartridges
  • Bottles
  • Ampules

Applications

  • Cancer
  • Diabetes
  • CNS
  • Infections
  • Cardiovascular Diseases

End-Users

  • Hospital & Clinics
  • Online Pharmacies
  • Home Care Settings

Regions

  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa

Key players in the global complex injectable market include Eli Lilly, Pfizer, Teva Pharmaceutical Industries, Hospira, Hikma Pharmaceutical, Johnson & Johnson Pharmaceutical, Novo Nordisk, and Abbvie.

Major companies are engaged in adopting several market strategies such as mergers & acquisitions, collaborations, partnerships, product launches, R&D activities, and capacity expansion to increase market share and global presence.

Manufacturers are concentrating on æimproving drug delivery and needle-free injectors. Long acting injectable (LAI) are gasping attention and is anticipated to gain prominence during the forecast period. Recent developments in the needle-free injector market include pre-filled syringes, auto injectors, pen injections, and wearable. Moreover, increasing prevalence of diseases such as diabetes, CNS, infections, and cardiovascular diseases is likely to boost the market during the forecast period.

 

Complex Injectable Market By Key Players

Buy Report